Aspiriant LLC’s Southern Company SO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$490K Buy
5,119
+191
+4% +$18K 0.01% 248
2026
Q1
$476K Buy
4,928
+460
+10% +$42.6K 0.01% 224
2025
Q4
$390K Buy
+4,468
New +$408K 0.01% 244
2018
Q3
Sell
-4,942
Closed -$229K 257
2018
Q2
$229K Sell
4,942
-3,046
-38% -$136K 0.02% 229
2018
Q1
$357K Buy
+7,988
New +$355K 0.03% 175
2017
Q4
Sell
-10,797
Closed -$531K 165
2017
Q3
$531K Sell
10,797
-1,584
-13% -$76.8K 0.04% 137
2017
Q2
$593K Sell
12,381
-1,317
-10% -$66K 0.05% 136
2017
Q1
$682K Sell
13,698
-2,187
-14% -$108K 0.06% 134
2016
Q4
$781K Sell
15,885
-1,076
-6% -$52.9K 0.07% 119
2016
Q3
$870K Buy
16,961
+2,205
+15% +$116K 0.09% 111
2016
Q2
$625K Sell
14,756
-1,713
-10% -$86.2K 0.06% 126
2016
Q1
$852K Buy
+16,469
New +$802K 0.08% 108

Other funds holding SO

Aspiriant LLC's SO Position: Q2 2026 in Review

Aspiriant LLC increased its Southern Company (SO) stake by 3.9% in Q2 2026, buying an estimated $18K and bringing the position to 5,119 shares worth $490K. The position accounts for 0.01% of the portfolio, ranked #248.

Aspiriant LLC first reported a position in SO in Q1 2016 and has held it in 12 quarters since. The position peaked at $870K in Q3 2016. 2,359 funds tracked by Wall St. Rank hold SO as of Q2 2026.

  • Aspiriant LLC held 5,119 shares of Southern Company worth $490K as of Q2 2026.
  • Aspiriant LLC bought 191 Southern Company shares in Q2 2026, an estimated $18K.
  • Southern Company made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #248 holding.
  • Aspiriant LLC first reported a position in Southern Company in Q1 2016 and has held it in 12 quarters since.
  • Aspiriant LLC's Southern Company position peaked at $870K in Q3 2016.
  • 2,359 funds tracked by Wall St. Rank held Southern Company as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.